In vivo pharmacological actions of F 11356, a novel high efficacy anti-migraine 5HT1B/1D receptor agonist.

被引:0
|
作者
John, GW [1 ]
Verscheure, Y [1 ]
Bel, L [1 ]
Perez, M [1 ]
Halazy, S [1 ]
Chopin, P [1 ]
Marien, M [1 ]
Colpaert, FC [1 ]
机构
[1] Ctr Rech Pierre Fabre, F-81106 Castres, France
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:405 / 405
页数:1
相关论文
共 50 条
  • [21] F 11356, a new 5-HT derivative, with selective, potent and high efficacy agonist properties at 5-HT1B/D receptors
    Pauwels, PJ
    Palmier, C
    Tardif, S
    Wurch, T
    Perez, M
    Carilla-Durand, E
    John, GW
    Halazy, S
    Colpaert, FC
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R523 - R523
  • [22] F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine
    John, GW
    Pauwels, PJ
    Perez, M
    Halazy, S
    Le Grand, B
    Verscheure, Y
    Valentin, JP
    Palmier, C
    Wurch, T
    Chopin, P
    Marien, M
    Kleven, MS
    Koek, W
    Assie, MB
    Carilla-Durand, E
    Tarayre, JP
    Colpaert, FC
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 290 (01) : 83 - 95
  • [23] Clinical Pharmacokinetics of Almotriptan, a Serotonin 5-HT1B/1D Receptor Agonist for the Treatment of Migraine
    Janet D. McEnroe
    Joseph C. Fleishaker
    Clinical Pharmacokinetics, 2005, 44 : 237 - 246
  • [24] Vasoconstrictive properties of the 5HT1B/1D agonists:: Response
    Dahlöf, CGH
    CEPHALALGIA, 1999, 19 (05) : 537 - 537
  • [25] An example of insufficient reporting of tolerability problems in reviews of an anti-migraine drug (the 5HT1F receptor agonist lasmiditan)
    Tfelt-Hansen, P.
    CEPHALALGIA, 2015, 35 : 18 - 18
  • [26] Are 5-HT1 receptor agonists effective anti-migraine drugs?
    Tanaka, Masaru
    Torok, Nora
    Vecsei, Laszlo
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (10) : 1221 - 1225
  • [27] SAR study on close analogs of F 11356:: A novel series of highly efficacious and selective H5HT1B/1D receptor agonists for the acute treatment of migraine
    Perez, M
    Pallard, I
    Fourrier, C
    Potier, P
    Pauwels, PJ
    Vaientin, JF
    John, GW
    Halazy, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U244 - U244
  • [28] Hemodynamic and coronary effects of intravenous eletriptan, a 5HT1B/1D-receptor agonist
    Muir, DF
    McCann, GP
    Swan, L
    Clark, AL
    Hillis, WS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 66 (01) : 85 - 90
  • [29] Neurophysiological evaluation of migraine attacks:: effects of 5HT1B/1D agonists on blink reflex.
    De Tommaso, M
    Sciruicchio, V
    Libro, G
    Puca, FM
    CEPHALALGIA, 1999, 19 (04) : 361 - 361
  • [30] Do 5HT1B/1D receptor agonists have an effect on mood and anxiety disorders?
    Morelli, Nicola
    Gori, Sara
    Choub, Anna
    Maluccio, Maria Rosaria
    Orlandi, Giovanni
    Guazzelli, Mario
    Murri, Luigi
    CEPHALALGIA, 2007, 27 (05) : 471 - 472